| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 22.66B | 21.26B | 21.73B | 23.00B | 22.64B |
| Gross Profit | 2.82B | 2.50B | 2.26B | 2.29B | 1.91B |
| EBITDA | 1.75B | 1.28B | 1.35B | 1.22B | 880.53M |
| Net Income | 1.23B | 1.06B | 625.55M | 1.12B | 866.61M |
Balance Sheet | |||||
| Total Assets | 23.60B | 21.42B | 21.98B | 20.82B | 17.49B |
| Cash, Cash Equivalents and Short-Term Investments | 4.25B | 3.81B | 3.92B | 3.36B | 1.32B |
| Total Debt | 1.51B | 1.87B | 1.83B | 1.82B | 1.09B |
| Total Liabilities | 12.14B | 10.78B | 12.06B | 11.09B | 8.51B |
| Stockholders Equity | 11.23B | 10.42B | 9.71B | 9.50B | 8.74B |
Cash Flow | |||||
| Free Cash Flow | 1.67B | 784.62M | 1.85B | 812.75M | 220.34M |
| Operating Cash Flow | 1.99B | 1.04B | 2.49B | 2.00B | 1.57B |
| Investing Cash Flow | -1.22B | -1.50B | -1.46B | -152.99M | -103.93M |
| Financing Cash Flow | -930.67M | -356.46M | -478.02M | 185.09M | -911.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$11.52B | 15.60 | 11.27% | 3.66% | 9.16% | 17.90% | |
68 Neutral | HK$7.74B | 14.09 | 11.69% | 1.98% | 11.37% | 17.71% | |
63 Neutral | HK$13.05B | 7.63 | 5.19% | 5.44% | 0.79% | -9.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$16.18B | 7.93 | 9.60% | 3.23% | 9.64% | -37.53% | |
55 Neutral | HK$6.66B | 7.47 | 7.70% | ― | -5.68% | -25.13% | |
45 Neutral | HK$1.03B | -7.57 | -15.41% | ― | -0.05% | -54.13% |